COLLECTIONS
WORKFLOWS
Lilly Asia Ventures is a leading biomedical venture capital firm that originated as a corporate venture subsidiary of Eli Lilly in 2008. It became an independent investment management company in 2011. The firm focuses on investments in life science companies, particularly in biopharmaceuticals and human therapeutics, with offices in Shanghai, Hong Kong, and Palo Alto.
Focus Areas
Investment Types
Notable Investments
